Breath testing devices and analytics

A portable electrochemical breathalyzer device addresses the need for affordable, non-invasive disease detection by measuring breath gases, enhancing diagnostic accuracy for conditions like Celiac disease and H. pylori through sensors and machine learning algorithms.

WO2025184435A1 Publication Date: 2025-09-04ANASTASIA RIGAS +1
4 Cites 0 Cited by

Patent Information

Application Number
PCT/US2025/017734
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-02-29
Filing Date
2025-02-27
Publication Date
2025-09-04

AI Technical Summary

Technical Problem

Current diagnostic methods for gastrointestinal, liver, and kidney diseases, as well as infections like H. pylori and cancer, are invasive, expensive, and lack affordable, portable, and user-friendly options, particularly for asymptomatic or subclinical conditions.

Method used

A universal electrochemical multianalyte breathalyzer device with sensors for ammonia and carbon dioxide detection, utilizing polyaniline and polypyrrole doped with specific dopants to measure breath gases, integrated with a processor and Bluetooth for data transfer, allowing self-administered point-of-care testing.

Benefits of technology

Provides accurate, non-invasive, and cost-effective detection of diseases by measuring breath gases, offering high sensitivity and specificity for conditions such as Celiac disease, H. pylori, and metabolic liver diseases, with potential for early intervention.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention provides an improved breath analyzer and breath test method to determine the presence of disease in humans, including but not limited to, H. pylori infection, Celiac Disease, Metabolic dysfunction-associated steatohepatitis (MAHD), Inflammatory Bowel Disease (JBD). 'm a subject's digestive tract. In certain embodiments, the present invention provides a universal breath testing platform and methods of testing for diseases of the gastrointestinal tract, the liver, the kidneys, and the lungs, along with testing for cancer, infections, and metabolic diseases.
Need to check novelty before this filing date? Find Prior Art